Opendata, web and dolomites

PhoRAu TERMINATED

Photochemistry and radiolabelling of gold(III) anticancer prodrugs

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PhoRAu project word cloud

Explore the words cloud of the PhoRAu project. It provides you a very rough idea of what is the project "PhoRAu" about.

tissues    offers    agents    localised    chemotherapy    modes    activated    bases    dark    remarkable    positron    stability    124    attempt    synthetic    complexes    undergo    treatment    shown    metals    photoactivatable    physiological    outstanding    clinics    nowadays    display    reactivity    medicinal    advantage    strikingly    cisplatin    drugs    carbene    synthesis    class    versatility    photochemistry    labelling    au    light    prodrugs    combining    compartments    radionuclide    organs    cancer    cell    plan    derivatives    photodynamic    emission    cytotoxicity    exploring    molecules    phototherapy    tomography    imaging    therapeutic    photochemotherapy    cells    simultaneously    chemical    destruction    transition    photophysical    killing    anticancer    temporal    pet    irradiation    reported    ideal    reducing    act    spatial    mechanisms    gold    metal    resistance    integration    guided    advantages    characterised    photochemical    world    antiproliferative    giving    activate    innovative    image    therapy   

Project "PhoRAu" data sheet

The following table provides information about the project.

Coordinator
FUNDACION DONOSTIA INTERNATIONAL PHYSICS CENTER 

Organization address
address: PASEO MANUEL LARDIZABAL 4
city: DONOSTIA SAN SEBASTIAN
postcode: 20018
website: http://dipc.ehu.es

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 158˙121 €
 EC max contribution 158˙121 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2016
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2018
 Duration (year-month-day) from 2018-03-01   to  2020-02-29

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FUNDACION DONOSTIA INTERNATIONAL PHYSICS CENTER ES (DONOSTIA SAN SEBASTIAN) coordinator 158˙121.00

Map

 Project objective

The use of light to activate anticancer prodrugs is nowadays a reality in clinics around the world. Photodynamic therapy is an effective treatment for the localised destruction of cancer cells in a range of tissues and organs. Triggering the antiproliferative activity of chemotherapy agents with spatial and temporal control offers the advantage of reducing side effects and resistance. On the bases of the great success of metal-based drugs (e.g. cisplatin and its derivatives), photoactivatable metal complexes have been investigated for their potential in light-activated therapy. This promising class of molecules is characterised by outstanding photophysical and photochemical features, which can result in novel cytotoxicity mechanisms. Among transition metals, gold has shown promising anticancer features, however no attempt to exploit Au photochemistry for medicinal use has been reported yet. This project aims at exploring such potential by investigating the development of innovative photoactivatable gold complexes that can be used as effective prodrugs for photochemotherapy and simultaneously act as imaging agents. In particular, the research plan involves the synthesis of novel gold(III) carbene complexes which display dark stability in physiological conditions and high reactivity under light irradiation. These systems can undergo controlled Au(III)/Au(I) reduction in cell compartments giving new cell killing modes and therapeutic advantages. Strikingly, their remarkable synthetic and chemical versatility are ideal for combining therapy and imaging capabilities through labelling with 124-I radionuclide for Positron Emission Tomography (PET). Integration of such features has the potential to deliver innovative image-guided agents for cancer phototherapy.

 Publications

year authors and title journal last update
List of publications.
2019 Alessio Terenzi, Hugo Gattuso, Angelo Spinello, Bernhard K. Keppler, Christophe Chipot, François Dehez, Giampaolo Barone, Antonio Monari
Targeting G-quadruplexes with Organic Dyes: Chelerythrine–DNA Binding Elucidated by Combining Molecular Modeling and Optical Spectroscopy
published pages: 472, ISSN: 2076-3921, DOI: 10.3390/antiox8100472
Antioxidants 8/10 2020-03-05
2019 Giovanni Salassa, Alessio Terenzi
Metal Complexes of Oxadiazole Ligands: An Overview
published pages: 3483, ISSN: 1422-0067, DOI: 10.3390/ijms20143483
International Journal of Molecular Sciences 20/14 2020-03-05

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PHORAU" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PHORAU" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

NeuroSens (2019)

Neuromodulation of Sensory Processing

Read More  

NPsVLCD (2019)

Natural Product-Inspired Therapies for Leishmaniasis and Chagas Disease

Read More  

POMOC (2019)

Charles IV and the power of marvellous objects

Read More